Why Biolase’s NewTom VG3 is a unique entry to the digital market

April 23, 2013

Travis Harrison of Biolase says it’s an exciting time for Biolase and the NewTom family as the NewTom VG3 introduces a new digital imaging hybrid technology to the market.

Travis Harrison of Biolase says it’s an exciting time for Biolase and the NewTom family as the NewTom VG3 introduces a new digital imaging hybrid technology to the market.

Harrison, imaging technology manager at Biolase, took a moment during this month’s “CDA Presents” meeting in Anaheim, Calif., to demonstrate the innovative, hybrid modality of the NewTom VG3.

The hybrid modality allows practices to expand digital imaging capabilities, assess its current state, and the opportunity to venture into new areas of digital dental imaging.

All in one unit, users can produce various types of digital imaging from panoramic to CBCT and more. Watch the video below to learn more about this unique hybrid modality.